Mike Polark
Stock Analyst at Baird
(0)
# 3190
Out of 5,291 analysts
95
Total ratings
42.22%
Success rate
0.58%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Inspire Medical Syst... | Maintains: Outperform | 252 248 | 156.92 | 58.04% | 6 | Feb 11, 2025 | |
Edwards Lifesciences | Downgrades: Underperform | 60 60 | 70.9 | -15.37% | 4 | Jan 16, 2025 | |
Nevro | Maintains: Neutral | 5 6 | 5.85 | 2.56% | 10 | Nov 12, 2024 | |
iRhythm Technologies | Maintains: Outperform | 100 79 | 105.05 | -24.8% | 7 | Nov 1, 2024 | |
ResMed | Downgrades: Underperform | 180 | 219.83 | -18.12% | 5 | Sep 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 405 | 364.44 | 11.13% | 1 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 55 55 | 39.12 | 40.59% | 8 | Aug 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 487 503 | 491.6 | 2.32% | 7 | Jul 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 200 | 258.63 | -22.67% | 2 | May 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 2 | Apr 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 3 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Peer Perform | n/a | n/a | n/a | 4 | Oct 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Peer Perform | n/a | n/a | n/a | 4 | Jul 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 3 | Apr 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 121 | 67.69 | 78.76% | 1 | Jan 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Jan 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 25 | 11.78 | 112.22% | 4 | Jan 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 165 | 163.5 | 0.92% | 3 | Sep 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 2 | Jul 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | n/a | n/a | n/a | 2 | Jul 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | 11.84 | 9.8% | 2 | Apr 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | 21 | 7.6 | 176.32% | 1 | Apr 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | 330 | n/a | n/a | 1 | Apr 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 79 | n/a | n/a | 2 | Jan 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 150 156 | n/a | n/a | 5 | Sep 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 230 250 | 222.94 | 12.14% | 2 | Aug 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Jun 24, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 43 | 1.97 | 2082.74% | 1 | Sep 2, 2020 |